Publication | Closed Access

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Hematological MalignancyOncologyGemtuzumab OzogamicinMixed-phenotype Acute LeukemiaAdult PatientsHematologyPharmacologyPharmacotherapyMedicineCancer ResearchMyeloid Neoplasia